Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021

SELL
$0.96 - $1.62 $13,035 - $21,997
-13,579 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$1.09 - $1.49 $7,210 - $9,856
-6,615 Reduced 32.76%
13,579 $19,000
Q1 2021

May 04, 2021

BUY
$1.26 - $2.02 $1,736 - $2,783
1,378 Added 7.32%
20,194 $27,000
Q4 2020

Feb 11, 2021

BUY
$0.9 - $1.54 $90 - $154
100 Added 0.53%
18,816 $25,000
Q3 2020

Nov 05, 2020

BUY
$0.87 - $2.08 $16,282 - $38,929
18,716 New
18,716 $17,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0

About CohBar, Inc.


  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.28M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.